These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 19720422

  • 1. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients.
    Chew V, Tow C, Teo M, Wong HL, Chan J, Gehring A, Loh M, Bolze A, Quek R, Lee VK, Lee KH, Abastado JP, Toh HC, Nardin A.
    J Hepatol; 2010 Mar; 52(3):370-9. PubMed ID: 19720422
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW, Chen YX, Wang ZM, Zhou LD, Li XY, Li LX, Luo QZ, Tian W, Fu CY, Zhou JH.
    Hepatogastroenterology; 2008 Mar; 55(82-83):345-50. PubMed ID: 18613363
    [Abstract] [Full Text] [Related]

  • 4. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D, Santos SJ, Baelde HJ, Taminiau AH, Egeler RM, Schilham MW, Hogendoorn PC, Lankester AC.
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ.
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma.
    Ikeguchi M, Oi K, Hirooka Y, Kaibara N.
    Eur J Surg Oncol; 2004 Feb; 30(1):53-7. PubMed ID: 14736523
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-2 gene expression is a new biological prognostic marker in hepatocellular carcinomas.
    Ikeguchi M, Hirooka Y.
    Onkologie; 2005 May; 28(5):255-9. PubMed ID: 15867481
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A, Tanaka F, Mimori K, Inoue H, Kai S, Shibata K, Ohta M, Kitano S, Mori M.
    Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
    [Abstract] [Full Text] [Related]

  • 11. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Matsubara T, Ono T, Yamanoi A, Tachibana M, Nagasue N.
    J Surg Oncol; 2007 Mar 01; 95(3):241-9. PubMed ID: 17323338
    [Abstract] [Full Text] [Related]

  • 12. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
    Sera T, Hiasa Y, Mashiba T, Tokumoto Y, Hirooka M, Konishi I, Matsuura B, Michitaka K, Udaka K, Onji M.
    Eur J Cancer; 2008 Mar 01; 44(4):600-8. PubMed ID: 18255279
    [Abstract] [Full Text] [Related]

  • 13. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.
    Hirano S, Iwashita Y, Sasaki A, Kai S, Ohta M, Kitano S.
    J Gastroenterol Hepatol; 2007 May 01; 22(5):690-6. PubMed ID: 17444857
    [Abstract] [Full Text] [Related]

  • 14. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.
    Chew V, Chen J, Lee D, Loh E, Lee J, Lim KH, Weber A, Slankamenac K, Poon RT, Yang H, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Abastado JP.
    Gut; 2012 Mar 01; 61(3):427-38. PubMed ID: 21930732
    [Abstract] [Full Text] [Related]

  • 15. PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.
    Noda T, Yamamoto H, Takemasa I, Yamada D, Uemura M, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H.
    Liver Int; 2012 Jan 01; 32(1):110-8. PubMed ID: 22098155
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.
    J Gastroenterol Hepatol; 2012 Jan 01; 27(1):173-80. PubMed ID: 21777276
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
    Hokuto D, Sho M, Yamato I, Yasuda S, Obara S, Nomi T, Nakajima Y.
    Eur J Cancer; 2015 Jan 01; 51(2):157-65. PubMed ID: 25468715
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.